½ÃÀ庸°í¼­
»óǰÄÚµå
1782480

¼¼°èÀÇ ´ÏÄÚÆ¾ ²­ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2033³â)

Global Nicotine Gum Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 111 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ´ÏÄÚÆ¾ ²­ ½ÃÀå ±Ô¸ð´Â 2024³â 20¾ï 7,000¸¸ ´Þ·¯¿¡¼­ 2033³â¿¡´Â 35¾ï 5,000¸¸ ´Þ·¯·Î ¼ºÀåÇϸç, 2026-2033³âÀÇ ¿¹Ãø ±â°£ Áß 6.18%ÀÇ °ß°íÇÑ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´ÏÄÚÆ¾ ²­ ½ÃÀåÀº ±Ý¿¬°ú ´ÏÄÚÆ¾ ¿å±¸¸¦ °ü¸®ÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ ¼Ö·ç¼ÇÀ» ã´Â »ç¶÷µéÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ´ÏÄÚÆ¾ ´ëü¿ä¹ý(NRT)ÀÇ ÇÑ ÇüÅÂÀÎ ´ÏÄÚÆ¾ ²­Àº Èí¿¬ÀÚ¿¡°Ô ±Ý´Ü Áõ»ó°ú Èí¿¬ ¿å±¸¸¦ ¿ÏÈ­ÇÏ´Â µ¿½Ã¿¡ ´ÏÄÚÆ¾¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ Á¡ÁøÀûÀ¸·Î °¨¼Ò½ÃŰ´Â ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. °øÁߺ¸°Ç ³ë·Â°ú ÀÎ½Ä °³¼± Ä·ÆäÀÎÀÌ ±Ý¿¬À» Àå·ÁÇÔ¿¡ µû¶ó ´ÏÄÚÆ¾ ²­¿¡ ´ëÇÑ ¼ö¿ä´Â Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¤ºÎ¿Í º¸°Ç±â°üÀÌ Èí¿¬À²À» ³·Ãß°í °Ç°­ÇÑ »ýȰ½À°üÀ» Àå·ÁÇϱâ À§ÇÑ Á¤Ã¥À» Áö¼ÓÀûÀ¸·Î ½ÃÇàÇϰí ÀÖÀ¸¹Ç·Î ÀÌ·¯ÇÑ Ãß¼¼´Â ƯÈ÷ °ü·ÃÀÌ ÀÖ½À´Ï´Ù.

¶ÇÇÑ °Ç°­°ú À£ºù¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ´ÏÄÚÆ¾ ²­ ½ÃÀå¿¡µµ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±Ý¿¬À» µ½°í Àü¹ÝÀûÀÎ °Ç°­À» ÁõÁø½ÃŰ´Â Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °¢ Á¦Á¶¾÷üµéÀº ¼ÒºñÀÚÀÇ ÃëÇâ¿¡ µû¶ó ´Ù¾çÇÑ ¸À°ú ¹èÇÕÀÇ ´ÏÄÚÆ¾ ²­À» °³¹ßÇÏ¿© ÀÌ·¯ÇÑ µ¿Çâ¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ±Ý¿¬À» À§ÇØ ¸Å·ÂÀûÀ̰í È¿°úÀûÀÎ ´ë¾ÈÀ» ã´Â »ç¶÷µéÀÌ ´Ã¾î³²¿¡ µû¶ó ÀÌ·¯ÇÑ ½ÃÀåÀÇ ´Ù¾çÈ­´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¶ÇÇÑ ¿¬±¸°³¹ßÀÇ ¹ßÀüÀº ´ÏÄÚÆ¾ ²­ÀÇ »óȲÀ» ¹Ù²Ù°í ÀÖ½À´Ï´Ù. ´ÏÄÚÆ¾ ²­ÀÇ È¿´ÉÀ» ³ôÀÌ°í »ç¿ëÀÚ °æÇèÀ» Çâ»ó½ÃŰ´Â »õ·Î¿î Á¦ÇüÀÇ °³¹ßÀº ½ÃÀåÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ð¹ÙÀÏ ¾Û ¹× ¿Â¶óÀÎ Áö¿ø ÇÁ·Î±×·¥°ú °°Àº µðÁöÅÐ °Ç°­ ±â¼úÀÇ ÅëÇÕÀº Èí¿¬ÀÚ¿¡°Ô ±Ý¿¬ ³ë·ÂÀ» Áö¿øÇÏ´Â Ãß°¡ ¸®¼Ò½º¿Í ÅøÀ» Á¦°øÇÕ´Ï´Ù. ÀÌó·³ ´ÏÄÚÆ¾ ²­ ½ÃÀåÀº °øÁß º¸°Ç¿¡ ´ëÇÑ ³ë·Â, ¼ÒºñÀÚ ¼±È£µµ º¯È­, ±Ý¿¬ ¼Ö·ç¼ÇÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î Å« ¼ºÀåÀ» ÀÌ·ê ¼ö ÀÖ´Â À§Ä¡¿¡ ÀÖ½À´Ï´Ù.

´ç»çÀÇ º¸°í¼­´Â °í°´¿¡°Ô ´Ù¾çÇÑ »ê¾÷°ú ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÌ°í ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇϱâ À§ÇØ ¼¼½ÉÇÏ°Ô ÀÛ¼ºµÇ¾ú½À´Ï´Ù. °¢ º¸°í¼­¿¡´Â ½ÃÀå »óȲÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱâ À§ÇÑ ¸î °¡Áö Áß¿äÇÑ ¿ä¼Ò°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä: Á¤ÀÇ, ºÐ·ù, »ê¾÷ ÇöȲ µî ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ¼Ò°³.

½ÃÀå ¿ªÇÐ: ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ ¹× °úÁ¦¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼­´Â ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È­, »õ·Î¿î µ¿Çâ µîÀÇ ¿äÀÎÀ» »ìÆìº¾´Ï´Ù.

¼¼ºÐÈ­ ºÐ¼® : À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª µîÀÇ ±âÁØ¿¡ µû¶ó ½ÃÀåÀ» ¸íÈ®ÇÑ ºÎ¹®À¸·Î ¼¼ºÐÈ­ÇÕ´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ °¢ ºÎ¹®ÀÇ ½ÇÀû°ú ¹Ì·¡¼ºÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ: ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû ±¸»ó, À繫 ½ÇÀû µî ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Æò°¡. ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇϰí ÀÖ´Â °æÀï ¿ªÇÐ ¹× ÁÖ¿ä Àü·«¿¡ ´ëÇÑ ÀλçÀÌÆ®À» ´ã°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿¹Ãø : °ú°Å µ¥ÀÌÅÍ¿Í ÇöÀç ½ÃÀå »óȲÀ» ¹ÙÅÁÀ¸·Î ÀÏÁ¤ ±â°£ ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Ãß¼¼¸¦ ¿¹ÃøÇÕ´Ï´Ù. ¿©±â¿¡´Â Á¤·®Àû ºÐ¼®°ú ¹Ì·¡ ½ÃÀå ±ËÀûÀ» º¸¿©ÁÖ´Â ±×·¡ÇÁ Ç¥½Ã°¡ Æ÷ÇԵ˴ϴÙ.

Áö¿ª ºÐ¼® : Áö¿ªº° ½ÃÀå ¼º°ú¸¦ Æò°¡Çϰí ÁÖ¿ä ½ÃÀå ¹× Áö¿ª µ¿ÇâÀ» ÆÄ¾ÇÇÕ´Ï´Ù. Áö¿ª ½ÃÀå ¿ªÇÐ ¹× ºñÁî´Ï½º ±âȸ¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

»õ·Î¿î µ¿Çâ°ú ±âȸ : ÇöÀç ½ÃÀå µ¿Çâ°ú »õ·Î¿î ½ÃÀå µ¿Çâ, ±â¼ú Çõ½Å, ÀáÀçÀû ÅõÀÚ ´ë»ó ºÎ¹®À» ½Äº°ÇÕ´Ï´Ù. ÇâÈÄ °³¹ß ¹× ¼ºÀå Àü¸Á¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ ´ã°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå ´ÏÄÚÆ¾ ²­ »ê¾÷ ºÐ¼®

  • ¼­·Ð - ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • »ê¾÷ µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿ø·á ºÐ¼®
    • ¿ø·á ¸®½ºÆ®
    • ¿ø·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿ø·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ´ÏÄÚÆ¾ ²­ ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • À¯Çüº° °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • 2mg
  • 4mg

Á¦6Àå ¼¼°èÀÇ ´ÏÄÚÆ¾ ²­ ½ÃÀå ºÐ¼® : À¯Åë ä³Îº°

  • À¯Åë ä³Îº° °³¿ä
  • À¯Åë ä³Îº° °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ½´ÆÛ¸¶ÄÏ/ÇÏÀÌÆÛ¸¶ÄÏ
  • ÆíÀÇÁ¡
  • ¾à±¹
  • ¿Â¶óÀÎ

Á¦7Àå ¼¼°èÀÇ ´ÏÄÚÆ¾ ²­ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ´ÏÄÚÆ¾ ²­ ±â¾÷ÀÇ °æÀï ±¸µµ

  • ´ÏÄÚÆ¾ ²­ ½ÃÀåÀÇ °æÀï
  • Á¦ÈÞ¡¤Çù·Â¡¤°è¾à
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Johnson & Johnson
  • Novartis AG
  • ITC Limited
  • Cipla Health Limited
  • Perrigo Company Plc.
  • Teva Canada
  • Philip Morris
  • British American Tobacco PLC
  • Revolymer
  • Fertin Pharma
KSA 25.08.12

Global Nicotine Gum Market size is anticipated to grow from USD 2.07 Billion in 2024 to USD 3.55 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.18% during the forecast period of 2026 to 2033.

The nicotine gum market is experiencing significant growth as more individuals seek effective solutions to quit smoking and manage nicotine cravings. Nicotine gum, a form of nicotine replacement therapy (NRT), provides smokers with a way to reduce withdrawal symptoms and cravings while gradually decreasing their dependence on nicotine. As public health initiatives and awareness campaigns promote smoking cessation, the demand for nicotine gum is expected to rise. This trend is particularly relevant as governments and health organizations continue to implement policies aimed at reducing smoking rates and promoting healthier lifestyles.

Moreover, the increasing focus on health and wellness is influencing the nicotine gum market. As consumers become more health-conscious, there is a growing demand for products that support smoking cessation and promote overall well-being. Manufacturers are responding to this trend by developing nicotine gum with various flavors and formulations that cater to different consumer preferences. This diversification is expected to drive market growth as more individuals seek appealing and effective options for quitting smoking.

Additionally, advancements in research and development are transforming the nicotine gum landscape. The development of new formulations that enhance the effectiveness of nicotine gum and improve user experience is driving innovation in the market. Furthermore, the integration of digital health technologies, such as mobile apps and online support programs, is providing smokers with additional resources and tools to aid in their cessation efforts. The nicotine gum market is thus positioned for significant growth, driven by public health initiatives, changing consumer preferences, and advancements in smoking cessation solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • 2mg
  • 4mg

By Distribution Channel

  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Pharmacies
  • Online
  • COMPANIES PROFILED
  • Johnson & Johnson
  • Novartis AG
  • ITC Limited
  • Cipla Health Limited
  • Perrigo Company Plc.
  • Teva Canada
  • Philip Morris
  • British American Tobacco PLC
  • Revolymer
  • Fertin Pharma.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. NICOTINE GUM INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Distribution Channel
    • 3.7.3 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL NICOTINE GUM MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. 2mg Historic and Forecast Sales By Regions
  • 5.4. 4mg Historic and Forecast Sales By Regions

6. GLOBAL NICOTINE GUM MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 6.1. Overview By Distribution Channel
  • 6.2. Historical and Forecast Data Analysis By Distribution Channel
  • 6.3. Supermarkets/Hypermarkets Historic and Forecast Sales By Regions
  • 6.4. Convenience Stores Historic and Forecast Sales By Regions
  • 6.5. Pharmacies Historic and Forecast Sales By Regions
  • 6.6. Online Historic and Forecast Sales By Regions

7. GLOBAL NICOTINE GUM MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE NICOTINE GUM COMPANIES

  • 8.1. Nicotine Gum Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF NICOTINE GUM INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Johnson & Johnson
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Novartis AG
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. ITC Limited
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Cipla Health Limited
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Perrigo Company Plc.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Teva Canada
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Philip Morris
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. British American Tobacco PLC
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Revolymer
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Fertin Pharma
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦